General: Lurasid is an atypical antipsychotic that has a unique chemical structure compared to other existing antischizophrenia drugs and is believed to have affinity for dopamine D2, serotonin (5-HTChemicalbook2A) and (5-HT 7) receptors and antagonistic effects in these receptors. Furthermore, lrasidone had a partial agonistic effect on the serotonin (5-HT 1 A) receptor and had no significant affinity for histamine H1 or muscarinic M1 receptors. It has been shown to mediate the efficacy of lursidone in schizophrenia through a combination of central-type 2 dopamine (D2) and type-25 HT 2 A receptor (5 HT 2 A) receptor antagonism.

Luracidon is an atypical antipsychotic drug, which was discovered and developed by Sumitomo Pharmaceutical. Compared with other existing anti-schizophrenia drugs, luresidone has a unique chemical structure.  

Function: Like other drugs that are effective in schizophrenia, the mechanism of action of luraci done is unknown. It has been shown that the efficacy of lur asidone in schizophrenia is mediated by the combination of type 2 central dopamine (D2) and type 2 5HT2A receptor antagonism. 

The findished product is an atypical antipsychotic drug used to treat schizophrenia. To establish efficacy in four 6-week controlled studies of adult schizophrenics.